课题基金 / 基金详情

Career Enhancement Program

Career Enhancement Program
职业提升计划
批准号:
10436170
负责人:
Alice Berger
金额:
$8.18万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-08-01 至 2024-05-31

项目摘要

项目成果

Alice Berger的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract – Career Enhancement Program The development of talented junior faculty into future leaders in their respective fields is a key goal of essential all successful research organizations. The Fred Hutch Lung SPORE Career Enhancement Program (CEP) will aspire to identify and nurture the careers of promising junior investigators and senior faculty interested in re-focusing their programs on lung cancer translational research. This will be accomplished through a calculated solicitation process to identify all talented junior investigators at the post-doctoral fellow level (must be in last year of training) and junior faculty level. We will also solicit applications from senior investigators who wish to re-focus their research programs on translational lung cancer research. A thorough review process will be performed by a highly accomplished panel of senior leaders at our Center who comprise the CEP Committee. In conjunction with the Executive Committee (EC), final award decisions will be made. The CEP Committee will closely monitor the progress of CEP Awardees throughout the duration of the award. The EC and CEP Committee will ensure that the awardees become immersed within the Lung SPORE and benefit the research expertise and available core resources. Self-assessments will be made by the Committee such that the effectiveness of the program can be carefully monitored and necessary adjustments made. Ongoing efforts at our Center will be leveraged to promote an environment of inclusion in which gender and ethnic diversity is promoted within the Lung SPORE.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding and exploiting novel therapeutic vulnerabilities of RIT1-driven lung cancer
Understanding and exploiting novel therapeutic vulnerabilities of RIT1-driven lung cancer
  • 批准号:
    10746367
  • 项目类别:
  • 资助金额:
    $13.57万
  • 财政年份:
    2021
  • 负责人:
    Alice Berger
  • 依托单位:
Understanding and exploiting novel therapeutic vulnerabilities of RIT1-driven lung cancer
  • 批准号:
    10641671
  • 项目类别:
  • 资助金额:
    $45.8万
  • 财政年份:
    2021
  • 负责人:
    Alice Berger
  • 依托单位:
Understanding and exploiting novel therapeutic vulnerabilities of RIT1-driven lung cancer
  • 批准号:
    10378686
  • 项目类别:
  • 资助金额:
    $46.74万
  • 财政年份:
    2021
  • 负责人:
    Alice Berger
  • 依托单位:
国内基金
海外基金
胚胎脑发育的分子机理:lgl2(late gestation lung 2)蛋白质的生物学功能的研究
  • 批准号:
    30470854
  • 项目类别:
    面上项目
  • 资助金额:
    18.0万元
  • 批准年份:
    2004
  • 负责人:
    陶涛
  • 依托单位: